Soolantra is the branded ivermectin 1% cream developed by Galderma for the treatment of papulopustular rosacea. Its price varies significantly depending on the country, tube volume, distributor, and pharmacy pricing policies. As a premium dermatology product, Soolantra is consistently more expensive than generic ivermectin 1% creams, which contain the same active ingredient but are produced at lower cost.
The higher cost of Soolantra reflects brand positioning, proprietary formulation, and clinical trial investment rather than differences in therapeutic effect. Patients seeking more affordable rosacea treatment often compare Soolantra with generic ivermectin creams, which offer similar efficacy at a fraction of the price. Understanding these pricing differences helps users choose the most cost‑effective option. Explore related resources: Soolantra cream, Ivermectin cream 1%, Ivermectin price.
Soolantra 1% cream (ivermectin 1%, Galderma) is positioned as a premium dermatology product, and its price reflects the branded formulation, cosmetic vehicle quality, and clinical positioning for papulopustular rosacea. Compared with generic ivermectin creams, Soolantra is consistently more expensive across all markets. Price variation also depends on tube volume, pharmacy distribution, and regional regulatory policies.
The 30 g tube is the most common retail size. It carries a high per‑gram cost due to the branded vehicle and dermatology‑grade formulation. This size is typically used for initial treatment courses and is priced significantly above generic ivermectin 1% creams.
The 45 g tube offers a slightly better cost‑per‑gram ratio but remains premium‑priced. It is often preferred for long‑term rosacea management. Despite the larger volume, the price difference compared with generics remains substantial.
Generic ivermectin 1% creams and gels are considerably cheaper due to simpler formulations and broader manufacturer competition. While the active ingredient is identical, generics lack the proprietary Galderma vehicle, which contributes to Soolantra’s higher cost.
| Volume | Concentration | Price range | Comment |
|---|---|---|---|
| 30 g | 1% | High | Most common size; premium dermatology pricing |
| 45 g | 1% | High | Better cost per gram but still premium |
| Generic ivermectin | 1% | Low–moderate | Same active ingredient; simpler vehicle |
Soolantra 1% cream (ivermectin 1%, Galderma) is positioned as a premium dermatology product, and its pricing reflects the branded vehicle, clinical positioning, and manufacturer strategy. The cost varies across regions, but in all markets Soolantra remains significantly more expensive than generic ivermectin 1% creams. Tube volume, distribution channel, and local regulatory policies further influence final retail pricing.
The 30 g tube is the most common retail size and typically carries the highest cost per gram. It is widely used for initial rosacea treatment courses. Key pricing drivers include:
As a result, the 30 g tube is priced well above generic ivermectin alternatives.
The 45 g tube offers a slightly better cost‑per‑gram ratio but remains premium‑priced. It is often chosen for long‑term rosacea management. Despite the larger size, the price gap between Soolantra and generics remains substantial due to the branded formulation.
Soolantra’s higher price reflects:
This brand premium is the primary reason Soolantra costs several times more than generic ivermectin creams.
Prices differ significantly across countries. High‑income regions typically show the highest retail prices due to regulatory frameworks and branded market dominance, while markets with strong generic competition may show wider price gaps.
| Volume | Concentration | Price range | Comment |
|---|---|---|---|
| 30 g | 1% | High | Most common size; highest cost per gram |
| 45 g | 1% | High | Better value per gram but still premium |
The price difference between Soolantra 1% and generic ivermectin 1% creams is one of the most significant in the topical antiparasitic and rosacea‑treatment market. Although both products contain the same active ingredient—ivermectin 1%—their formulations, tolerability profiles, and market positioning differ substantially. A detailed comparison is available at Ivermectin vs Soolantra.
Both Soolantra and generic ivermectin creams contain ivermectin 1%. The therapeutic mechanism is identical, targeting Demodex mites and reducing inflammatory lesions in rosacea.
The key difference lies in the vehicle. Soolantra uses a proprietary Galderma cream base designed for:
Generic creams typically use simpler, more basic vehicles.
Soolantra’s branded vehicle generally provides superior tolerability, especially for sensitive rosacea‑prone skin. Generics may be slightly heavier or less refined, though still effective.
Soolantra is priced several times higher than generic ivermectin creams due to:
Generics remain the most cost‑efficient option for many patients.
| Product | Concentration | Price range | Comment |
|---|---|---|---|
| Soolantra (Galderma) | 1% | High | Premium vehicle; dermatology‑grade formulation |
| Generic ivermectin cream | 1% | Low–moderate | Same active ingredient; simpler base |
| Price difference | 1% | Wide variation | Soolantra often 3–6× more expensive |
The cost of Soolantra 1% cream varies depending on the clinical scenario, treatment duration, and whether alternative therapies are considered. Although Soolantra contains the same active ingredient as generic ivermectin 1% creams, its premium Galderma formulation places it at the higher end of the pricing spectrum. The following overview is informational and reflects general pricing tendencies across dermatologic indications. Additional context is available at Ivermectin for rosacea, Ivermectin for demodex, Ivermectin for acne.
For papulopustular rosacea, Soolantra is one of the most commonly prescribed topical agents. Because rosacea often requires long‑term management, the cost of Soolantra can accumulate over time. The branded vehicle, clinical trial support, and dermatology‑grade formulation contribute to its higher price compared with generic ivermectin creams. Patients using Soolantra for several months typically incur higher overall treatment costs.
In cases where rosacea is strongly linked to Demodex overgrowth, Soolantra is frequently selected due to its targeted anti‑Demodex activity and superior tolerability. Treatment may require extended use, making cost an important consideration. Generic ivermectin creams offer a more economical alternative, but Soolantra’s smoother, more hydrating base may be preferred for sensitive skin, influencing the cost–benefit balance.
For acneiform rosacea presentations, Soolantra may be used off‑label or as part of a broader dermatologic strategy. These cases often require prolonged therapy, which increases cumulative cost. Because acne‑like rosacea can involve fluctuating severity, patients may use Soolantra intermittently or in combination with other agents, further affecting overall expenses.
| Clinical scenario | Preferred form | Price range | Comment |
|---|---|---|---|
| Rosacea | Topical 1% cream | High | Long‑term use increases total cost |
| Demodex‑associated rosacea | Topical 1% cream | High | Premium vehicle; often preferred for sensitive skin |
| Acne‑like rosacea | Topical 1% cream | High | Off‑label; cost varies with treatment duration |
The price of Soolantra 1% cream (ivermectin 1%, Galderma) is shaped by a combination of branding, formulation complexity, market conditions, and the availability of generic alternatives. As a premium dermatology product, Soolantra consistently occupies the upper tier of topical rosacea treatments. Understanding the key cost drivers helps explain why Soolantra is significantly more expensive than generic ivermectin creams despite sharing the same active ingredient.
The strongest contributor to Soolantra’s high price is the Galderma brand premium. This includes:
Brand positioning alone places Soolantra far above generic ivermectin in cost.
Soolantra is typically sold in 30 g and 45 g tubes. While the 45 g tube offers a slightly better cost‑per‑gram ratio, both sizes remain premium‑priced. Smaller tubes often carry the highest per‑gram cost due to packaging and distribution overhead.
Prices vary significantly across regions. High‑income countries tend to have the highest retail prices due to regulatory frameworks, branded market dominance, and pharmacy markups. In contrast, markets with strong generic competition may show wider price gaps between Soolantra and generic ivermectin.
Pharmacies, wholesalers, and online retailers apply their own commercial markups. These policies can substantially influence final retail pricing, especially in regions with limited competition or where dermatology products are positioned as premium skincare.
The presence of generic ivermectin 1% creams significantly affects Soolantra’s market price. Generics offer the same active ingredient at a fraction of the cost, creating downward pressure on Soolantra pricing—but the branded formulation remains several times more expensive due to its proprietary vehicle and clinical positioning.
| Cost factor | Impact |
|---|---|
| Galderma branding | Major premium due to proprietary vehicle |
| Tube volume | Larger tubes reduce cost per gram |
| Country of manufacture | Regulation and market competition affect price |
| Distributor policy | Markup varies by pharmacy and region |
| Generic alternatives | Generics are far cheaper; widen price gap |
Soolantra 1% cream (ivermectin 1%, Galderma) is one of the most expensive topical agents used for rosacea and Demodex‑associated dermatoses. Its premium pricing reflects the branded vehicle, dermatology‑grade formulation, and clinical trial support. When compared with generic ivermectin, metronidazole, azelaic acid, benzyl benzoate, and permethrin, Soolantra consistently occupies the highest price tier. Additional context is available at Ivermectin price, Ivermectin vs Metronidazole, Ivermectin vs Azelaic acid, Ivermectin vs Benzyl benzoate, Ivermectin vs Permethrin.
Both contain ivermectin 1%, but the difference lies in the vehicle. Soolantra uses a proprietary Galderma cream base with superior cosmetic elegance and tolerability. Generic ivermectin creams use simpler formulations, making them dramatically cheaper. The price gap is often 3–6× in favor of generics.
Metronidazole creams and gels are significantly cheaper and widely available as generics. While metronidazole is effective for inflammatory rosacea, it is generally less potent for Demodex‑associated cases. Soolantra is more expensive but offers stronger efficacy in Demodex‑driven rosacea.
Azelaic acid 15–20% occupies a mid‑range price category. Premium brands (e.g., Finacea) may approach Soolantra’s cost, but generics remain cheaper. Azelaic acid can cause irritation, whereas Soolantra is typically better tolerated.
Benzyl benzoate and permethrin are extremely inexpensive antiparasitic topicals. However, they are not optimized for rosacea and may cause irritation, especially on facial skin. Soolantra is far more expensive but significantly safer and more suitable for chronic dermatologic use.
| Treatment | Typical price | Comment |
|---|---|---|
| Soolantra (Galderma) | Very high | Premium dermatology formulation; proprietary vehicle |
| Generic ivermectin 1% cream | Low–moderate | Same active ingredient; simpler base |
| Metronidazole | Low | Cheapest rosacea topical; widely available generics |
| Azelaic acid | Moderate | Price varies by brand; may cause irritation |
| Benzyl benzoate | Very low | Highly irritating; not suitable for facial rosacea |
| Permethrin | Low | Inexpensive antiparasitic; not optimized for rosacea |
The economic efficiency of Soolantra 1% cream (ivermectin 1%, Galderma) depends on how its premium price aligns with clinical performance, tolerability, and duration of therapeutic effect. Although Soolantra is one of the most expensive topical agents used for rosacea and Demodex‑associated dermatoses, its branded formulation offers advantages that may influence overall cost‑effectiveness in long‑term management. The following overview is informational and reflects general pricing logic rather than treatment recommendations.
Soolantra demonstrates strong clinical efficacy in papulopustular rosacea and Demodex‑associated inflammation. Its targeted anti‑Demodex activity and anti‑inflammatory properties often lead to visible improvement within several weeks. Because effective treatments reduce flare frequency and the need for additional therapies, Soolantra’s higher upfront cost may be partially offset by improved long‑term outcomes. However, generic ivermectin creams provide similar pharmacological action at a much lower price, making the economic advantage dependent on individual tolerability and response.
Soolantra’s proprietary Galderma vehicle is formulated for high tolerability, especially for sensitive rosacea‑prone skin. Reduced irritation means fewer treatment interruptions, better adherence, and lower risk of switching to alternative therapies. Generics, while effective, may have heavier or less refined cream bases, which can affect comfort and adherence. This tolerability advantage contributes to Soolantra’s perceived economic value despite its premium price.
Soolantra provides a durable therapeutic effect when used consistently, helping maintain remission in chronic rosacea. Long‑term stability reduces the need for frequent regimen changes or combination therapy. However, because rosacea often requires months of continuous treatment, the cumulative cost of Soolantra remains significantly higher than that of generic ivermectin creams.
| Economic factor | Impact |
|---|---|
| Clinical effectiveness | Strong efficacy may offset part of the cost |
| Tolerability | High tolerability improves adherence and stability |
| Duration of effect | Long‑term remission reduces need for additional therapy |
| Overall value | Premium cost; generics remain more economical |